AwardedSpainGoods€65,755,960
Suministro de medicamentos de uso humano cuyos principios activos son Vandetanib, Sarilumab, Dupilumab, Rasburicasa Y Avalglucosidasa Alfa con destino a los centros del ámbito de la sanidad pública valenciana.
- Published
- Published 26 June 2025
Overview
Suministro de medicamentos de uso humano cuyos principios activos son Vandetanib, Sarilumab, Dupilumab, Rasburicasa Y Avalglucosidasa Alfa con destino a los centros del ámbito de la sanidad pública valenciana.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €65,755,960
- Procedure
- Direct
- Published
- 26 June 2025
Medicinal products for the alimentary tract and metabolismMedicinal products for dermatologyAntineoplastic agentsImmunosuppressive agentsPharmaceutical articles
Award outcome
- Awarded value
- €15,656,181
- Award date
- 22 May 2025
- SANOFI AVENTIS, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
26 June 2025
Contracting authority
Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad
Procuring entityValencia, Spain
ID_PLATAFORMA: 20897030133463
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.